Krystof; Vladimir

Patent Applications and Registrations

Patent applications and USPTO patent grants for Krystof; Vladimir.The latest application filed is for "5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)h-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma".

Company Profile

1.12.13

Krystof; Vladimir - Olomouc CZ
Krystof; Vladimir - Ostrava CZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma Grant 11,186,583 - Havlicek , et al. November 30, 2	2021-11-30
2,6-disubstituted-9-cyclopentyl-9H-purines, use thereof as medicaments, and pharmaceutical compositions Grant 11,028,087 - Gucky , et al. June 8, 2	2021-06-08
5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)h-pyrazolo[4,3-d]pyrimidines For Treatment Of Lymphoma App 20200361943 - HAVLICEK; Libor ; et al.	2020-11-19
2,6-disubstituted-9-cyclopentyl-9h-purines, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20200087306 - GUCKY; TOMAS ; et al.	2020-03-19
5-substituted 7- [4-(2-pyridyl)phenylmethylamino] -3-isopropylpyrazolo4,3-D]pyrimidine derivatives, use thereof as medicaments, and pharmaceutical compositions Grant 9,957,273 - Havlicek , et al. May 1, 2	2018-05-01
5-substituted 7-[4-(2-pyridyl)phenylmethylamino]-3-isopropylpyrazolo4,3-d]pyrimidine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20180072736 - HAVLICEK; Libor ; et al.	2018-03-15
2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20150368248 - GUCKY; Tomas ; et al.	2015-12-24
Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds Grant 9,023,857 - Havlicek , et al. May 5, 2	2015-05-05
Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives App 20140066394 - SZUCOVA; Lucie ; et al.	2014-03-06
Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives Grant 8,492,391 - Zatloukal , et al. July 23, 2	2013-07-23
4-arylazo-3,5-diamino-pyrazole compounds and use thereof Grant 8,357,673 - Cankar , et al. January 22, 2	2013-01-22
Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives App 20120070512 - Zatloukal; Marek ; et al.	2012-03-22
Substituted 6-(2-aminobenzylamino)purine Derivatives, Their Use As Medicaments And Preparations Containing These Compounds App 20110287111 - Havlicek; Libor ; et al.	2011-11-24
Substituted [1,2,3] triazolo[4,5-D]pyrimidines as cdk inhibitors Grant 7,816,350 - Fuksova , et al. October 19, 2	2010-10-19
Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy Grant 7,745,450 - Moravcova , et al. June 29, 2	2010-06-29
4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof App 20080312238 - Cankar; Petr ; et al.	2008-12-18
"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use" App 20070167466 - Moravcova; Daniela ; et al.	2007-07-19
Azapurine derivatives App 20060035909 - Fuksova; Kveta ; et al.	2006-02-16
Pyrazolo[4,3-D]pyrimidines, processes for their preparation and methods for therapy App 20050080097 - Moravcova, Daniela ; et al.	2005-04-14
Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof App 20030191086 - Hanus, Jan ; et al.	2003-10-09
Purine derivatives, process for their preparation and use thereof App 20030187261 - Havlicek, Libor ; et al.	2003-10-02
Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof Grant 6,552,192 - Hanus , et al. April 22, 2	2003-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.